MedTrace Logo

Effects of H.Pylori Eradication on Microbiome

NCT03231332 · Status: ENROLLING_BY_INVITATION · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2018-08-22

No results posted yet for this study

Summary

The aim of this Project is, within the scope of industrial research, to evaluate the long term effects of H.pylori eradication on microbiome (gut microbiome, upper respiratory tract microbiome) and lasting adverse events. In addition, the project aims to evaluate its effects on abundance and prevalence of extended-spectrum beta-lactamases coding genes and develop cost effective ESBL screening test prototype.

Conditions

  • Human Microbiome

Interventions

OTHER

Microbiome Diversity detection

detection of microbiome composition and detection of specific mutations in genes conferring resistance to antibiotics

Sponsors & Collaborators

  • Latvian Biomedical Research and Study Centre

    collaborator OTHER_GOV

  • University of Latvia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-29
Primary Completion
2019-10-29
Completion
2025-12-31

Countries

  • Latvia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03231332 on ClinicalTrials.gov